Page 2 - Optimal Management of Urologic Oncology During COVID-19
P. 2
Speakers & Disclosures
Anil Kapoor Aly-Khan Lalani
Professor of Surgery (Urology) & Oncology Assistant Professor,
McMaster University Department of Oncology
Chair, Genito-Urinary Oncology Program McMaster University
Juravinski Cancer Centre Medical Oncologist
Juravinski Cancer Centre
Disclosures: Disclosures:
Honoraria: Amgen, BMS, Merck, Novartis, Pfizer, Honoraria: AbbVie, Astellas, BMS, Eisai, Ipsen,
Roche, Eisai, Ipsen, Verity Janssen, Merck, Novartis, Pfizer, Roche, TerSera
Grants: Amgen, Novartis, Pfizer Grants: Novartis, Roche, Ipsen, EMD Serrono
Clinical Trials: Amgen, Novartis, Pfizer, CCTG, Clinical Trials: BMS, Merck
BMS, Merck